[Yariko]

читайте [Ссылки доступны только зарегистрированным пользователям ]

if, after quantative risk assessment, a risk-based treatment decision is uncertain, assessment of > 1 of the following - family history, hs-CRP, CAC score or ABI - may be considered to inform treatment decision making (IIB B)

[Ссылки доступны только зарегистрированным пользователям ]

7. Recommendations for Measurement of C-Reactive Protein


Class IIb

1. In asymptomatic intermediate-risk men 50 years of age or younger or women 60 years of age or younger, measurement of CRP may be reasonable for cardiovascular risk assessment.14,20 (Level of Evidence: B)